HighVista Strategies »

Compass Pathways shares owned by HighVista Strategies

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.4M 499k 6.90

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Compass Pathways

Deep Track Capital
Rtw Investments
Tang Capital Management
BIT Capital GmbH
ARK Investment Management
Millennium Management
GMT Capital Corp
Two Sigma Investments
DAFNA Capital Management
Baker Bros. Advisors
Eagle Health Investments
UBS Group
Susquehanna International
Leucadia National Corporation
Aisling Capital Management

View all funds holding Compass Pathways